AvidBiologics' Series B Round

AvidBiologics raised a round of funding on September 29, 2014.

AvidBiologics is a private Canadian biotechnology development company created to be Canada's first to concentrate solely on Antibody-Drug Conjugates (ADCs). The company is a 2011 spin-out from YM BioS…

Articles about AvidBiologics' Series B Round: